What Is an IgG4 Test and What Do the Results Mean?

An IgG4 test is a blood test that measures the concentration of immunoglobulin G subclass 4, the least abundant of the four IgG subtypes circulating in your bloodstream. Doctors most often order it when they suspect IgG4-related disease, a condition in which affected organs become inflamed and scarred, but elevated or abnormal IgG4 levels also turn up in allergies, infections, cancers, and several autoimmune conditions. The results are useful but far from definitive on their own, and how they’re interpreted depends heavily on the clinical picture surrounding them.

What IgG4 Actually Does

IgG4 makes up only a small fraction of the total IgG in your blood, yet it behaves quite differently from the other three subclasses. Its signature trick is something called Fab-arm exchange: half of one IgG4 molecule can swap with half of another, producing a hybrid antibody that can bind two different targets but only one of each. As a result, roughly 99% of circulating IgG4 is functionally unable to cross-link antigens or form large immune complexes the way other antibodies do.¹ That makes IgG4 a poor trigger of inflammation in most settings. In health, it appears to contribute to immune tolerance, helping your body calm down its response to things like allergens after prolonged exposure. During allergen-specific immunotherapy, for instance, rising IgG4 levels compete with IgE for allergen binding and help shut down mast-cell reactions.²

This dual personality is what makes interpreting an IgG4 test tricky. The same molecule that helps enforce tolerance in one context is the hallmark of a serious inflammatory disease in another.

IgG4-Related Disease

The most common clinical reason to order a serum IgG4 test is suspicion of IgG4-related disease, often abbreviated IgG4-RD. This is a systemic condition in which IgG4-positive immune cells infiltrate tissues, causing inflammation, fibrosis, and eventually organ damage if untreated.³ It can affect almost any organ, though the pancreas, bile ducts, salivary glands, tear glands, kidneys, and lymph nodes are among the most frequent targets. The classic presentation in the pancreas is autoimmune pancreatitis, which can mimic pancreatic cancer on imaging and sometimes leads to unnecessary surgery if misdiagnosed.

Patients with salivary and lacrimal gland involvement tend to have higher serum IgG4 levels than those with internal organ involvement alone, and IgG4 levels generally climb as more organs are affected.⁴ But the disease is not defined by the blood test. The gold standard for diagnosis remains a tissue biopsy showing a specific pattern: dense infiltration by plasma cells, a distinctive swirling fibrosis pattern called storiform fibrosis, and inflamed veins that can be partly or fully blocked.⁵ The serum test is one piece of evidence layered on top of clinical symptoms, imaging, and pathology findings.⁶

How Accurate Is the Blood Test?

The serum IgG4 test is helpful but imperfect. A large meta-analysis pooling data from multiple studies found that at the standard cutoff, the test had a sensitivity of about 87% and a specificity of about 83%. That means it correctly flags most people who have IgG4-RD, but it also gives false positives in a meaningful number of people who don’t.⁷ A more recent and larger meta-analysis reported broadly similar numbers, with pooled sensitivity of 86% and specificity of 90%, but it also noted that about one in ten people without IgG4-RD still had elevated serum IgG4.⁸

Doubling the cutoff threshold improves specificity to roughly 95%, but sensitivity drops to around 63%, meaning you’d miss more than a third of true cases.⁷ There’s no single cutoff that solves both problems at once. This is why clinicians treat the result as one clue rather than a verdict. A positive serum IgG4 doesn’t confirm IgG4-RD, and a normal level doesn’t rule it out. Diagnosis should follow a comprehensive evaluation including clinical symptoms, lab work, imaging, and tissue pathology.⁸

Lab Pitfalls That Can Skew Your Results

Even the raw number on your lab report deserves a closer look. Most labs measure IgG4 using a technique called immunonephelometry, and the two most widely used platforms give results that correlate well but differ in absolute values by about 50% at the upper limit of normal.⁹ That means a result from one lab isn’t directly comparable to a result from another unless you know which platform was used.

A more dangerous artifact is the hook effect, sometimes called the prozone phenomenon. When IgG4 levels are extremely high, the excess antibody can overwhelm the assay and produce a falsely low or even normal reading. Cases have been reported in the literature where patients with severe IgG4-RD appeared to have normal IgG4 levels because the test essentially choked on the abundance. If the clinical suspicion is strong but the number looks unexpectedly low, labs can dilute the sample and re-run it to check for this error.⁹ Mass spectrometry has been proposed as an alternative that eliminates these analytical issues, and some centers are adopting it.

When IgG4 Is Elevated but It’s Not IgG4-RD

Elevated serum IgG4 is not unique to IgG4-related disease. A variety of other conditions can push levels above the normal range, and this is one of the main reasons the test has limited positive predictive value when used in isolation. Elevated IgG4 can appear in allergic conditions, certain cancers (particularly pancreatic and biliary cancers), chronic infections including parasitic helminth infections, and other autoimmune diseases.⁸

The overlap with pancreatic cancer is especially important. Autoimmune pancreatitis from IgG4-RD can look nearly identical to pancreatic cancer on imaging, and both can produce elevated IgG4. MRI features combined with serum IgG4 levels help distinguish the two, and certain imaging signs like a duct-penetration sign tend to correlate with higher IgG4 levels in autoimmune pancreatitis while being absent in cancer.¹⁰ Still, a tissue biopsy is often needed to settle the question definitively.

Among autoimmune conditions, elevated IgG4 has been found in rheumatoid arthritis, Sjögren’s syndrome, and systemic lupus erythematosus, though the clinical significance differs. In some of these diseases, IgG4 antibodies may actually be protective rather than harmful.¹¹ In others, such as a specific form of myasthenia gravis, IgG4 autoantibodies directly cause symptoms by blocking protein interactions at the neuromuscular junction rather than through the complement-driven tissue damage typical of other antibody subclasses.¹² Similar blocking-type IgG4 autoantibodies have been identified in pemphigus vulgaris, membranous nephropathy, and autoimmune encephalitis.¹³

What a Low IgG4 Level Means

Because most attention goes to elevated levels, low IgG4 can fly under the radar. Selective IgG4 deficiency, where IgG4 is abnormally low while other immunoglobulin subclasses remain normal, is an under-recognized condition. In one study of 55 adults with selective IgG4 deficiency, the most common problem was recurrent infections, seen in about 60% of patients, with upper respiratory tract infections being the most frequent type.¹⁴

Case reports illustrate what this can look like in practice. One described a patient with persistent purulent sinusitis over several years that didn’t respond to repeated rounds of antibiotics and sinus procedures. Workup eventually revealed IgG4 levels around 3 to 4 mg/L, far below normal. Treatment with intravenous immunoglobulin infusions improved both the IgG4 levels and the sinus symptoms.¹⁵ If you’re dealing with stubborn, recurring infections, especially in the sinuses and respiratory tract, and standard treatments keep failing, an IgG subclass panel that includes IgG4 is worth discussing with your doctor.

Tracking Treatment Response in IgG4-Related Disease

Once IgG4-RD is diagnosed, serum IgG4 takes on a second role as a monitoring tool. Levels typically fall after treatment with corticosteroids or B-cell-depleting therapies like rituximab, and this decline can reassure your care team that the treatment is working.¹⁶ However, the drop isn’t always neat. Levels don’t necessarily return to normal even when the disease goes quiet clinically, so a persistently elevated number doesn’t automatically mean treatment has failed.

A rising IgG4 level during remission, on the other hand, can signal a brewing flare. A UK cohort study found that patients whose IgG4 levels were very high at diagnosis were more likely to have multi-organ involvement and a higher risk of relapse.¹⁷ Research on rituximab-treated patients has similarly shown that rising IgG4 after therapy can predict disease recurrence.¹⁸ In practice, most clinicians track the trend line rather than fixating on any single value.

The Food-Specific IgG4 Testing Controversy

If you’ve encountered IgG4 testing outside a hospital setting, it was likely through a direct-to-consumer food-sensitivity panel. Dozens of online companies sell tests that measure food-specific IgG or IgG4 antibodies and then provide a list of foods you’re supposedly intolerant to. These are a different test from the total serum IgG4 used in clinical medicine, but they trade on the same molecule’s name.

Professional allergy organizations have been blunt about these panels. The Canadian Society of Allergy and Clinical Immunology concluded that food-specific IgG4 testing should not be performed for diagnosing food allergy or intolerance, stating that it is not a reliable predictor of clinical reactivity to foods and may instead simply reflect immune tolerance to things you eat regularly.¹⁹ The European and American allergy societies have issued similar positions. The logic is straightforward: your immune system naturally makes IgG4 against proteins you’re frequently exposed to. Finding IgG4 antibodies to milk, wheat, or eggs in someone who regularly eats those foods tells you their immune system has encountered those proteins, not that those proteins are causing harm.

Despite this consensus, the tests remain widely available. An investigation of online companies offering direct-to-consumer food-allergy testing found that only one out of more than twenty identified had proper laboratory accreditation for clinically recognized testing; the rest used IgG-based methods or bioresonance and involved a nutritionist at most rather than a physician.²⁰ If you’ve received results from one of these panels and eliminated a long list of foods, it’s worth speaking with an allergist before restricting your diet further. True food allergies are diagnosed through IgE testing, skin prick tests, and supervised oral food challenges.

There is one area where food-specific IgG4 has research interest rather than consumer marketing: eosinophilic esophagitis. In patients with this condition, food-specific IgG4 levels in esophageal tissue have been shown to correlate with markers of disease activity, particularly for milk and wheat proteins.²¹ This is tissue-level research, not a commercial blood panel, and it doesn’t validate the consumer tests, but it does hint that IgG4 plays a real biological role in certain gastrointestinal immune conditions.

IgG4 and Repeated Vaccination

A newer area of research emerged during and after the COVID-19 pandemic. Several studies reported that repeated mRNA vaccination was associated with a class switch toward IgG4 among anti-spike antibodies. The mechanism isn’t fully defined, but one plausible explanation involves the prolonged presence of spike protein from mRNA vaccines keeping germinal centers active for months, creating the kind of sustained antigen exposure that favors IgG4 production.²² Three factors that seem to drive this class switch are high antigen concentration, repeated doses, and the vaccine platform itself.²³

What this means clinically is still debated. Because IgG4 is an anti-inflammatory antibody that dampens immune responses, some researchers have raised questions about whether an IgG4-dominant response could reduce the effectiveness of future immune protection. Others point out that IgG4 class-switching isn’t unique to mRNA vaccines and has been observed with other repeatedly administered vaccines too.²⁴ The current evidence remains correlative rather than proof of a clinical problem, and this is an area where the science is actively evolving. If you see IgG4 mentioned in connection with vaccination on social media, it’s worth knowing that the finding is real but its practical significance remains an open question among immunologists.

When to Ask About IgG4 Testing

Most people will never need an IgG4 test. It isn’t part of routine bloodwork and shouldn’t be ordered as a screening test in otherwise healthy people. Situations where it becomes relevant include unexplained organ swelling or dysfunction, especially of the pancreas, salivary glands, kidneys, or bile ducts; imaging findings suggestive of autoimmune pancreatitis or retroperitoneal fibrosis; and unexplained multi-organ inflammatory disease. In those contexts, a serum IgG4 combined with the rest of the clinical workup helps point toward or away from IgG4-RD.

For patients already diagnosed with IgG4-RD, the test serves as one of several markers for tracking disease activity over time, with trends mattering more than any single snapshot. And if you’re being pitched a food-specific IgG4 panel by a wellness company, the professional allergy community’s position is clear: save your money. The real clinical value of IgG4 testing lies in specialized diagnostic settings, not in telling you which foods to avoid at dinner.

1
Gut. The dual role of IgG4 in immunity: bridging pathophysiology and therapeutic applications
2
PubMed Central. Role of IgG4 Antibodies in Human Health and Disease
3
PubMed Central. IgG4-related disease – focus on digestive system involvement
4
PubMed Central. Types of Organ Involvement in Patients with Immunoglobulin G4-related Disease
5
PubMed. Histopathology of IgG4-related disease
6
Mayo Clinic Proceedings. What Is an IgG4 Test and What Do the Results Mean?
7
PubMed Central. Diagnostic Value of Serum IgG4 for IgG4-Related Disease: A PRISMA-compliant Systematic Review and Meta-analysis
8
BMJ Open. Diagnostic utility of serum IgG4 level in IgG4-related diseases: a comprehensive systematic review and meta-analysis
9
Haematologica. IgG4-related disease: what a hematologist needs to know
10
PubMed. Differential Diagnosis of IgG4-related Pancreatitis and Pancreatic Cancer by MRI Features and Its Correlation with Serum IgG4 Level
11
PubMed Central. The Role of IgG4 in Autoimmunity and Rheumatic Diseases
12
PubMed Central. Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases
13
PubMed Central. IgG4-mediated autoimmune diseases: a niche of antibody-mediated disorders
14
Annals of Medical Research. Clinical and immunological features of 55 adult patients with selective IgG4 subclass deficiencies
15
PubMed Central. Chronic sinusitis in a patient with selective IgG4 subclass deficiency controlled with enriched immunoglobulins
16
Rheumatology Advances in Practice. Current and future advances in practice: IgG4-related disease
17
PubMed. Elevated Serum IgG4 Levels in Diagnosis, Treatment Response, Organ Involvement, and Relapse in a Prospective IgG4-Related Disease UK Cohort
18
PubMed Central. Therapeutic Uses of Rituximab and Clinical Features in Immunoglobulin G4-Related Disease: A Systematic Review
19
PubMed Central. CSACI Position statement on the testing of food-specific IgG
20
PubMed. Issues surrounding consumer-bought food-allergy testing
21
PubMed Central. Food-specific IgG4 is elevated throughout the upper gastrointestinal tract in eosinophilic esophagitis
22
Scientific Reports. Vaccination-first immune priming shapes a sustained mRNA vaccine-induced IgG4 class switch that associates with SARS-CoV-2 breakthrough infection risk
23
PubMed Central. IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein
24
PubMed. Mechanisms and implications of IgG4 responses to SARS-CoV-2 and other repeatedly administered vaccines